AstraZeneca plc (LON:AZN)
77% of retail CFD accounts lose money.
|Dividend Rate (ttm)||2.0905|
|Trading Day||Jun 10|
|Day's Range||98.51 - 100.56|
|52 Week Range||78.99 - 110|
About AstraZeneca plc
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
LON:AZN stock is currently trading at £98.51 as of 04:00 AM UTC, Jun 10, 2022. Use the financials tab to find out more about AstraZeneca plc's key financial metrics and recent earnings reports, or track its share price in real time on the chart tab. If you would like to buy shares in AstraZeneca plc, our detailed guide explains how to buy AstraZeneca plc stock.
AstraZeneca plc dividends
Astrazeneca plc has a market cap or net worth of £152.64 billion. The enterprise value is £0.
Astrazeneca plc has 1.55 billion shares outstanding.
The trailing PE ratio is 0.0000 and the forward PE ratio is 0.0000. Astrazeneca plc's PEG ratio is 0.0000.
Stock Price Statistics
The stock price has increased by 0.1538%. The beta is 0.0000, so Astrazeneca plc's price volatility has been lower than the market average.
In the last 12 months, Astrazeneca plc had revenue of £0 and earned £0 in profits. Earnings per share was £.